See the DrugPatentWatch profile for Symproic
What does Symproic do in the body? (Mechanism of action)
Symproic (naldemedine) is an opioid receptor antagonist. It works mainly in the periphery to block opioid receptors in the gut, which helps prevent or relieve opioid-related constipation without reversing pain control in the brain.
How does it treat opioid-induced constipation?
Opioids reduce intestinal movement by activating opioid receptors in the gastrointestinal tract, leading to constipation. By antagonizing those peripheral opioid receptors, naldemedine restores normal gastrointestinal function and increases bowel movement.
Why doesn’t it reverse opioid pain relief the same way?
Naldemedine is designed to act largely outside the central nervous system. Because it blocks opioid receptors in the gastrointestinal tract more than in the brain, it can improve constipation while keeping opioid analgesia relatively intact.
What to expect clinically from this mechanism?
Since it targets opioid-driven gut motility changes, the main pharmacologic effect is an increase in bowel activity in people taking opioids, rather than a direct laxative-like chemical action unrelated to opioid signaling.
Sources
No sources were provided in the prompt for Symproic’s mechanism of action. If you share the relevant reference text (labeling, article, or DrugPatentWatch.com page), I can cite it precisely.